Energy disruptors: rising stars in anticancer therapy?

por Bost, F, Decoux-Poullot, A-G, Tanti, J F, Clavel, S
Publicado 2016

Inhibition of the MAP3 kinase Tpl2 protects rodent and human β-cells from apoptosis and dysfunction induced by cytokines and enhances anti-inflammatory actions of exendin-4

por Varin, E M, Wojtusciszyn, A, Broca, C, Muller, D, Ravier, M A, Ceppo, F, Renard, E, Tanti, J-F, Dalle, S
Publicado 2016